Anti-tumor effect of neratinib against lung cancer cells harboring HER2 oncogene alterations

Human epidermal growth factor receptor 2 (HER2) is a member of the ErbB family of receptor tyrosine kinases. Numerous studies have reported the amplification and overexpression of HER2 in several types of cancer, including non-small cell lung cancer (NSCLC). However, the benefits of HER2-targeted th...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncol Lett
Autors principals: Ogoshi, Yusuke, Shien, Kazuhiko, Yoshioka, Takahiro, Torigoe, Hidejiro, Sato, Hiroki, Sakaguchi, Masakiyo, Tomida, Shuta, Namba, Kei, Kurihara, Eisuke, Takahashi, Yuta, Suzawa, Ken, Yamamoto, Hiromasa, Soh, Junichi, Toyooka, Shinichi
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2019
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6365915/
https://ncbi.nlm.nih.gov/pubmed/30854046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.9908
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars